These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1370341)

  • 1. Expression of the Evi-1 zinc finger gene in 32Dc13 myeloid cells blocks granulocytic differentiation in response to granulocyte colony-stimulating factor.
    Morishita K; Parganas E; Matsugi T; Ihle JN
    Mol Cell Biol; 1992 Jan; 12(1):183-9. PubMed ID: 1370341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter.
    Bartholomew C; Ihle JN
    Mol Cell Biol; 1991 Apr; 11(4):1820-8. PubMed ID: 1848663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
    Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
    Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
    Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
    Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
    Sitailo S; Sood R; Barton K; Nucifora G
    Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
    Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
    Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EVI-1 gene--its role in pathogenesis of human leukemias.
    Jółkowska J; Witt M
    Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
    Kreider BL; Orkin SH; Ihle JN
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6454-8. PubMed ID: 8341654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.
    Sood R; Talwar-Trikha A; Chakrabarti SR; Nucifora G
    Leukemia; 1999 Mar; 13(3):348-57. PubMed ID: 10086725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor Evi-1.
    Hirai H
    Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
    Oval J; Smedsrud M; Taetle R
    Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
    Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
    Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain.
    Tanaka T; Nishida J; Mitani K; Ogawa S; Yazaki Y; Hirai H
    J Biol Chem; 1994 Sep; 269(39):24020-6. PubMed ID: 7929053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.
    Delwel R; Funabiki T; Kreider BL; Morishita K; Ihle JN
    Mol Cell Biol; 1993 Jul; 13(7):4291-300. PubMed ID: 8321231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
    Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
    Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
    Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
    Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.
    Perkins AS; Fishel R; Jenkins NA; Copeland NG
    Mol Cell Biol; 1991 May; 11(5):2665-74. PubMed ID: 2017172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
    Tokita K; Maki K; Mitani K
    Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
    Nishikata I; Sasaki H; Iga M; Tateno Y; Imayoshi S; Asou N; Nakamura T; Morishita K
    Blood; 2003 Nov; 102(9):3323-32. PubMed ID: 12816872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.